459 related articles for article (PubMed ID: 38003477)
1. Blood-Brain Barrier Breakdown in Alzheimer's Disease: Mechanisms and Targeted Strategies.
Alkhalifa AE; Al-Ghraiybah NF; Odum J; Shunnarah JG; Austin N; Kaddoumi A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003477
[TBL] [Abstract][Full Text] [Related]
2. Reconsidering the role of blood-brain barrier in Alzheimer's disease: From delivery to target.
Sousa JA; Bernardes C; Bernardo-Castro S; Lino M; Albino I; Ferreira L; Brás J; Guerreiro R; Tábuas-Pereira M; Baldeiras I; Santana I; Sargento-Freitas J
Front Aging Neurosci; 2023; 15():1102809. PubMed ID: 36875694
[TBL] [Abstract][Full Text] [Related]
3. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
Deane R; Zlokovic BV
Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246
[TBL] [Abstract][Full Text] [Related]
4. The blood-brain barrier in Alzheimer's disease: novel therapeutic targets and nanodrug delivery.
Sharma HS; Castellani RJ; Smith MA; Sharma A
Int Rev Neurobiol; 2012; 102():47-90. PubMed ID: 22748826
[TBL] [Abstract][Full Text] [Related]
5. Abundance of P-Glycoprotein and Other Drug Transporters at the Human Blood-Brain Barrier in Alzheimer's Disease: A Quantitative Targeted Proteomic Study.
Storelli F; Billington S; Kumar AR; Unadkat JD
Clin Pharmacol Ther; 2021 Mar; 109(3):667-675. PubMed ID: 32885413
[TBL] [Abstract][Full Text] [Related]
6. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
Yamazaki Y; Kanekiyo T
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
[TBL] [Abstract][Full Text] [Related]
7. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
Kurz C; Walker L; Rauchmann BS; Perneczky R
Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
[TBL] [Abstract][Full Text] [Related]
8. Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease.
Erickson MA; Banks WA
J Cereb Blood Flow Metab; 2013 Oct; 33(10):1500-13. PubMed ID: 23921899
[TBL] [Abstract][Full Text] [Related]
9. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism.
Ma Q; Zhao Z; Sagare AP; Wu Y; Wang M; Owens NC; Verghese PB; Herz J; Holtzman DM; Zlokovic BV
Mol Neurodegener; 2018 Oct; 13(1):57. PubMed ID: 30340601
[TBL] [Abstract][Full Text] [Related]
10. Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.
Sagare AP; Bell RD; Zlokovic BV
J Alzheimers Dis; 2013; 33 Suppl 1(0 1):S87-100. PubMed ID: 22751174
[TBL] [Abstract][Full Text] [Related]
11. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
Bell RD; Zlokovic BV
Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
[TBL] [Abstract][Full Text] [Related]
12. New therapeutic targets in the neurovascular pathway in Alzheimer's disease.
Zlokovic BV
Neurotherapeutics; 2008 Jul; 5(3):409-14. PubMed ID: 18625452
[TBL] [Abstract][Full Text] [Related]
13. Role of Blood-Brain Barrier in Alzheimer's Disease.
Cai Z; Qiao PF; Wan CQ; Cai M; Zhou NK; Li Q
J Alzheimers Dis; 2018; 63(4):1223-1234. PubMed ID: 29782323
[TBL] [Abstract][Full Text] [Related]
14. Blood-Brain Barrier Disruption Increases Amyloid-Related Pathology in TgSwDI Mice.
Abdallah IM; Al-Shami KM; Yang E; Kaddoumi A
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513818
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease: A matter of blood-brain barrier dysfunction?
Montagne A; Zhao Z; Zlokovic BV
J Exp Med; 2017 Nov; 214(11):3151-3169. PubMed ID: 29061693
[TBL] [Abstract][Full Text] [Related]
17. HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.
Festoff BW; Sajja RK; van Dreden P; Cucullo L
J Neuroinflammation; 2016 Aug; 13(1):194. PubMed ID: 27553758
[TBL] [Abstract][Full Text] [Related]
18. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.
Deane R; Bell RD; Sagare A; Zlokovic BV
CNS Neurol Disord Drug Targets; 2009 Mar; 8(1):16-30. PubMed ID: 19275634
[TBL] [Abstract][Full Text] [Related]
19. [Blood-brain barrier and Alzheimer's disease].
Kuwahara H; Nishida Y; Yokota T
Brain Nerve; 2013 Feb; 65(2):145-51. PubMed ID: 23399672
[TBL] [Abstract][Full Text] [Related]
20. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
